MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer
Open Access
- 8 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-11
- https://doi.org/10.1038/s41598-021-84816-3
Abstract
Neoadjuvant chemo-radiotherapy (CRT) followed by total mesorectal excision (TME) represents the standard treatment for patients with locally advanced (≥ T3 or N+) rectal cancer (LARC). Approximately 15% of patients with LARC shows a complete response after CRT. The use of pre-treatment MRI as predictive biomarker could help to increase the chance of organ preservation by tailoring the neoadjuvant treatment. We present a novel machine learning model combining pre-treatment MRI-based clinical and radiomic features for the early prediction of treatment response in LARC patients. MRI scans (3.0 T, T2-weighted) of 72 patients with LARC were included. Two readers independently segmented each tumor. Radiomic features were extracted from both the “tumor core” (TC) and the “tumor border” (TB). Partial least square (PLS) regression was used as the multivariate, machine learning, algorithm of choice and leave-one-out nested cross-validation was used to optimize hyperparameters of the PLS. The MRI-Based “clinical-radiomic” machine learning model properly predicted the treatment response (AUC = 0.793, p = 5.6 × 10–5). Importantly, the prediction improved when combining MRI-based clinical features and radiomic features, the latter extracted from both TC and TB. Prospective validation studies in randomized clinical trials are warranted to better define the role of radiomics in the development of rectal cancer precision medicine.Keywords
This publication has 64 references indexed in Scilit:
- Long-term Follow-up Features on Rectal MRI During a Wait-and-See Approach After a Clinical Complete Response in Patients With Rectal Cancer Treated With ChemoradiotherapyDiseases of the Colon & Rectum, 2011
- Repeated double cross validationJournal of Chemometrics, 2009
- The influence of total mesorectal excision on local recurrence and survival in rectal cancer patients: A population‐based study in greater AmsterdamJournal of Surgical Oncology, 2006
- Preoperative versus Postoperative Chemoradiotherapy for Rectal CancerThe New England Journal of Medicine, 2004
- Morphological changes in tumour type after radiotherapy are accompanied by changes in gene expression profile but not in clinical behaviourThe Journal of Pathology, 2004
- Algorithmic Stability and Sanity-Check Bounds for Leave-One-Out Cross-ValidationNeural Computation, 1999
- AFNI: Software for Analysis and Visualization of Functional Magnetic Resonance NeuroimagesComputers and Biomedical Research, 1996
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaThe New England Journal of Medicine, 1991
- RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCERThe Lancet, 1986
- The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized InversesSIAM Journal on Scientific and Statistical Computing, 1984